Publikationen von Sascha Young Kupke
Alle Typen
Zeitschriftenartikel (17)
2024
Zeitschriftenartikel
108, 97 (2024)
Production of antiviral “OP7 chimera” defective interfering particles free of infectious virus. Applied Microbiology and Biotechnology
Zeitschriftenartikel
27 (4), 109421 (2024)
Mathematical model calibrated to in vitro data predicts mechanisms of antiviral action of the influenza defective interfering particle “OP7”. iScience 2023
Zeitschriftenartikel
13, 20936 (2023)
Generation of “OP7 chimera” defective interfering influenza A particle preparations free of infectious virus that show antiviral efficacy in mice. Scientific Reports
Zeitschriftenartikel
107, S. 5947 - 5961 (2023)
Production of retroviral vectors in continuous high cell density culture. Applied Microbiology and Biotechnology
Zeitschriftenartikel
15 (9), 1872 (2023)
Broad-Spectrum Antiviral Activity of Influenza A Defective Interfering Particles against Respiratory Syncytial, Yellow Fever, and Zika Virus Replication In Vitro. Viruses 2022
Zeitschriftenartikel
259, 104544 (2022)
Absolute quantification of viral proteins during single-round replication of MDCK suspension cells. Journal of Proteomics 2021
Zeitschriftenartikel
19 (1), 91 (2021)
Cell culture-based production and in vivo characterization of purely clonal defective interfering influenza virus particles. BMC Biology
Zeitschriftenartikel
105, S. 7251 - 7264 (2021)
Cell culture–based production of defective interfering influenza A virus particles in perfusion mode using an alternating tangential flow filtration system. Applied Microbiology and Biotechnology
Zeitschriftenartikel
105 (1), S. 129 - 146 (2021)
OP7, a novel influenza A virus defective interfering particle: production, purification, and animal experiments demonstrating antiviral potential. Applied Microbiology and Biotechnology
Zeitschriftenartikel
95 (24), e01174-21 (2021)
Semi-continuous propagation of influenza A virus and its defective interfering particles: analyzing the dynamic competition to select candidates for antiviral therapy. Journal of Virology
Zeitschriftenartikel
10 (7), 1756 (2021)
Antiviral Activity of Influenza A Virus Defective Interfering Particles against SARS-CoV-2 Replication In Vitro through Stimulation of Innate Immunity. Cells
Zeitschriftenartikel
17, e1009357 (2021)
Multiscale model of defective interfering particle replication for influenza A virus infection in animal cell culture. PLoS Computational Biology 2020
Zeitschriftenartikel
12 (1), 71 (2020)
Single-Cell Analysis Uncovers a Vast Diversity in Intracellular Viral Defective Interfering RNA Content Affecting the Large Cell-to-Cell Heterogeneity in Influenza A Virus Replication. Viruses 2019
Zeitschriftenartikel
93 (4), 01786-18 (2019)
A Novel Type of Influenza A Virus-Derived Defective Interfering Particle with Nucleotide Substitutions in Its Genome. Journal of Virology
Zeitschriftenartikel
15 (2), e1006819 (2019)
Multiscale modeling of influenza A virus replication in cell cultures predicts infection dynamics for highly different infection conditions. PLoS Computational Biology 2016
Zeitschriftenartikel
100 (16), S. 7181 - 7192 (2016)
Influenza virus intracellular replication dynamics, release kinetics, and particle morphology during propagation in MDCK cells. Applied Microbiology and Biotechnology 2015
Zeitschriftenartikel
6, 8938 (2015)
Single-cell analysis and stochastic modelling unveil large cell-to-cell variability in influenza A virus infection. Nature Communications Konferenzbeitrag (1)
2018
Konferenzbeitrag
51 (19), S. 32 - 33 (2018)
A multiscale model of influenza A virus replication covering highly different infection conditions in cell cultures. IFAC-PapersOnLine Meeting Abstract (3)
2023
Meeting Abstract
53 (2) Special Issue: SI Aufl., P339. Joint Conference of the Société Française d'Immunologie (SFI) and the Deutsche Gesellschaft für Immunologie (DGfI), Strasbourg (France), 26. September 2023 - 29. September 2023. Wiley-VCH, Weinheim (2023)
Characterization of the local innate immune response after mucosal application of IAV Defective Interfering Particles. In European Journal of Immunology, 2019
Meeting Abstract
Continuous mode of production for two classes of defective interfering influenza A virus particles as antiviral candidates. In Integrated Continuous Biomanufacturing IV, 76. Biomanufact IV, Ocean Edge Resort Brewster (Cape Cod), Massachusetts, USA , 06. Oktober 2019 - 10. Oktober 2019. (2019)